Despite tremendous medical treatment successes, colorectal cancer (CRC) remains a
leading cause of cancer deaths worldwide. Chemotherapy as monotherapy can lead to …

A substantial increase in colorectal cancer (CRC)–associated fatalities can be attributed to
tumor recurrence and multidrug resistance. Traditional treatment options, including radio …

Frequent development of resistance to chemotherapeutic agents such as 5-flourouracil (5-
FU) complicates the treatment of advanced colorectal cancer (CRC). Resveratrol is able to …

Malignant tumors remain one of the main sources of morbidity and mortality around the
world. A chemotherapeutic approach to cancer treatment poses a multitude of challenges …

The integrity of intestinal barrier determines intestinal homeostasis, which could be affected
by various factors, like physical, chemical, and biological stimuli. Therefore, it is of …

Colorectal cancer (CRC) is a common type of malignant digestive tract tumor with a high
incidence rate worldwide. Currently, the clinical treatment of CRC predominantly include …

Colorectal cancer (CRC) is the third most common cancer diagnosed worldwide making it a
serious global challenge. CRC progression results from dysregulated cytoplasmic …

Therapeutic targeting of Sp1 transcription factor and survivin, are studied in various cancers
due to their consistent overexpression. These markers result in poorer cancer prognoses …

Xylooligosaccharides having various degrees of polymerization such as xylobiose,
xylotriose, and xylotetraose positively affect human health by interacting with gut proteins …

The resistance of colorectal cancer (CRC) to conventional therapeutic modalities, such as
radiation therapy and chemotherapy, along with the associated side effects, significantly …